Inventor · disambiguated record
Thales Papagiannakopoulos
Also filed as: PAPAGIANNAKOPOULOS THALES
1 granted patent·4 pending applications·0 citations·filing 2018–2024
12Inventor score
Files withUNIV NEW YORK5
Top patents by PatentIndex Score
5 records- 0165US2024261245A1Methods of treating cancers having a deregulated nrf2/keap1 pathwayUNIV NEW YORK·Filed 2023·Application pending·0 cites
- 0259US2025073321A1Modulation of Oxidative Stress and Amino Acid Metabolism for the Treatment or Prevention of Diseases and DisordersUNIV NEW YORK·Filed 2024·Application pending·0 cites
- 0357US2024150845A1Therapeutic strategies to target tumors with alterations in lkb1 pathwayUNIV NEW YORK·Filed 2023·Application pending·0 cites
- 0450US2021361603A1Methods of treating cancers having a deregulated nrf2/keap1 pathwayUNIV NEW YORK·Filed 2018·Application pending·0 cites
- 0544US12186377B2Modulation of oxidative stress and amino acid metabolism for the treatment or prevention of diseases and disordersUNIV NEW YORK·Filed 2020·Granted Jan 7, 2025·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Thales Papagiannakopoulos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →